Explore more publications!

Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

Press releases published on April 13, 2026

Industry Highlight: SATPRO – Setting a New Standard for Clinician Safety in Interventional Radiology and Cardiology
Top High Speed Handpiece Manufacturers Driving a New Standard in Dental Equipment
Top Desiccant Manufacturers Driving Change in Global Moisture Control Markets
Sunway Medical Centre Penang Recognized as Emerging Tertiary Medical Hub – Malaysia by Global Brand Frontier Awards 2025
Vietnam's Vinmec Elevates High-Tech Healthcare Standards in Asia with Robotics and Next-Gen Diagnostics
Cervical Cancer Treatment Market to Reach US$14.6 bn by 2033 Says Persistence Market Research
Jeio Tech Celebrates 10-Year Partnership with Seeding Labs to Advance Global Scientific Research
Fitness2020 Opens in East Lake, Bringing Premium Fitness to One of Atlanta's Most Storied Communities
BoxLogix Parcel Named Mushiny’s Integrator of the Year
Crestron Recognizes The ProMedia Group Among Top 10 Fastest Growing Dealers Nationally
SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT)
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants
Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE)
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions